Matt Scribner Sells 2,500 Shares of Inogen Inc (INGN) Stock

Inogen Inc (NASDAQ:INGN) EVP Matt Scribner sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, March 15th. The shares were sold at an average price of $73.85, for a total value of $184,625.00. Following the sale, the executive vice president now owns 4,833 shares of the company’s stock, valued at approximately $356,917.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Matt Scribner also recently made the following trade(s):

  • On Tuesday, January 17th, Matt Scribner sold 2,500 shares of Inogen stock. The stock was sold at an average price of $63.91, for a total value of $159,775.00.

Inogen Inc (NASDAQ:INGN) opened at 76.44 on Tuesday. Inogen Inc has a 12 month low of $39.57 and a 12 month high of $79.94. The stock’s 50 day moving average price is $69.41 and its 200-day moving average price is $63.62. The stock has a market cap of $1.57 billion, a PE ratio of 78.80 and a beta of 1.07.

Insider Buying and Selling by Quarter for Inogen (NASDAQ:INGN)

Your IP Address:

Several equities research analysts recently issued reports on INGN shares. Needham & Company LLC upped their price target on Inogen from $66.00 to $78.00 and gave the stock a “strong-buy” rating in a report on Thursday, January 19th. Zacks Investment Research downgraded Inogen from a “strong-buy” rating to a “hold” rating in a report on Monday, February 6th. JPMorgan Chase & Co. set a $78.00 price objective on Inogen and gave the company a “buy” rating in a research note on Wednesday, March 1st. Stifel Nicolaus upped their price objective on Inogen to $65.00 in a research note on Wednesday, March 1st. Finally, TheStreet upgraded Inogen from a “c” rating to a “b-” rating in a research note on Tuesday, February 28th. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $68.17.

Hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. raised its position in shares of Inogen by 3.6% in the third quarter. JPMorgan Chase & Co. now owns 443,200 shares of the medical technology company’s stock worth $26,548,000 after buying an additional 15,425 shares during the period. New York State Common Retirement Fund raised its position in shares of Inogen by 2.0% in the third quarter. New York State Common Retirement Fund now owns 211,440 shares of the medical technology company’s stock worth $12,665,000 after buying an additional 4,225 shares during the period. Peregrine Capital Management LLC purchased a new position in shares of Inogen during the third quarter worth about $24,965,000. BlackRock Investment Management LLC raised its position in shares of Inogen by 0.7% in the third quarter. BlackRock Investment Management LLC now owns 67,727 shares of the medical technology company’s stock worth $4,057,000 after buying an additional 449 shares during the period. Finally, Cadence Capital Management LLC raised its position in shares of Inogen by 2.6% in the fourth quarter. Cadence Capital Management LLC now owns 15,312 shares of the medical technology company’s stock worth $1,029,000 after buying an additional 393 shares during the period.

About Inogen

Inogen, Inc is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds.

5 Day Chart for NASDAQ:INGN

Receive News & Ratings for Inogen Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nike Suspends Relationship with Maria Sharapova
Nike Suspends Relationship with Maria Sharapova
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Ron Washington Leaves Texas Rangers Due to an Affair
Ron Washington Leaves Texas Rangers Due to an Affair
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Tony Stewart Case Going to the Grand Jury
Tony Stewart Case Going to the Grand Jury
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder


Leave a Reply

 
© 2006-2017 Web Breaking News.